We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
On Holding
ONON
$12.6B
| $254K | ﹤0.01% |
8,178
-17,449
| -68% | -$395K |
|
1502
inTEST
INTT
$167M
| $253K | ﹤0.01% |
+12,217
| New | +$183K |
|
1503
Toro Company
TTC
$9.06B
| $253K | ﹤0.01% |
2,276
-2,285
| -50% | -$254K |
|
1504
Liberty Broadband Class C
LBRDK
$4.86B
| $250K | ﹤0.01% |
3,059
-7,392
| -71% | -$638K |
|
|
PDCE
1505
DELISTED
PDC Energy, Inc.
PDCE
| $250K | ﹤0.01% |
3,892
-14,872
| -79% | -$962K |
|
1506
Jackson Financial
JXN
$8.8B
| $250K | ﹤0.01% |
+6,676
| New | +$274K |
|
1507
SAP
SAP
$219B
| $250K | ﹤0.01% |
+1,973
| New | +$231K |
|
|
ALLK
1508
DELISTED
Allakos
ALLK
| $250K | ﹤0.01% |
+56,103
| New | +$359K |
|
1509
CALL
CME Group
CME
$95.7B
| $249K | ﹤0.01% |
1,300
-2,700
| -68% | -$488K |
|
|
NTST
1510
NETSTREIT Corp
NTST
$2.08B
| $249K | ﹤0.01% |
+13,611
| New | +$263K |
|
1511
Essent Group
ESNT
$6.15B
| $249K | ﹤0.01% |
+6,207
| New | +$256K |
|
1512
BioXcel Therapeutics
BTAI
$26.2M
| $249K | ﹤0.01% |
+832
| New | +$355K |
|
1513
Pennant Group
PNTG
$1.4B
| $248K | ﹤0.01% |
+17,400
| New | +$218K |
|
1514
Life Time Group Holdings
LTH
$9.87B
| $248K | ﹤0.01% |
+15,543
| New | +$266K |
|
1515
Waters Corp
WAT
$36.8B
| $247K | ﹤0.01% |
+799
| New | +$258K |
|
1516
Tapestry
TPR
$31.4B
| $247K | ﹤0.01% |
5,737
-17,240
| -75% | -$740K |
|
1517
Adicet Bio
ACET
$86.4M
| $247K | ﹤0.01% |
+2,682
| New | +$337K |
|
1518
Rush Enterprises Class A
RUSHA
$6.29B
| $247K | ﹤0.01% |
+6,780
| New | +$245K |
|
1519
PUT
Estee Lauder
EL
$30.6B
| $246K | ﹤0.01% |
1,000
| – | – |
|
1520
Metallus
MTUS
$851M
| $246K | ﹤0.01% |
+13,415
| New | +$251K |
|
1521
Evolent Health
EVH
$353M
| $246K | ﹤0.01% |
7,579
-2,493
| -25% | -$78.8K |
|
1522
Thor Industries
THO
$4.03B
| $245K | ﹤0.01% |
3,082
-769
| -20% | -$67.8K |
|
1523
Stellantis
STLA
$21.3B
| $245K | ﹤0.01% |
13,451
-2,034
| -13% | -$34K |
|
1524
Benchmark Electronics
BHE
$2.91B
| $244K | ﹤0.01% |
+10,312
| New | +$261K |
|
1525
CoreCivic
CXW
$3B
| $244K | ﹤0.01% |
+26,529
| New | +$272K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.